Insys Therapeutics Inc. (INSY) Stock Price, Forecast & Analysis
USA - NASDAQ:INSY -
INSY Key Statistics, Chart & Performance
The current stock price of INSY is 0.2911 null. In the past month the price decreased by -69.62%. In the past year, price decreased by -96.43%.
INSY Latest News, Press Relases and Analysis
About INSY
Company Profile
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Company Info
Insys Therapeutics Inc.
1333 S. Spectrum Blvd Suite 100
Chandler AZ 85286
CEO: Saeed Motahari
Phone: 480-500-3127
Insys Therapeutics Inc. / INSY FAQ
Can you describe the business of Insys Therapeutics Inc.?
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Can you provide the latest stock price for Insys Therapeutics Inc.?
The current stock price of INSY is 0.2911 null. The price decreased by -1.36% in the last trading session.
Does INSY stock pay dividends?
INSY does not pay a dividend.
How is the ChartMill rating for Insys Therapeutics Inc.?
INSY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in Insys Therapeutics Inc. be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INSY.
INSY Technical Analysis
INSY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to INSY. INSY has a bad profitability rating. Also its financial health evaluation is rather negative.
INSY Financial Highlights
Over the last trailing twelve months INSY reported a non-GAAP Earnings per Share(EPS) of -1.7400000000000002. The EPS decreased by -145.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -346.48% | ||
| ROA | -132.09% | ||
| ROE | 139.25% | ||
| Debt/Equity | -0.07 |